Latest filing published 24 Sept 2024 for Foghorn Therapeutics Inc., €322k.
Filing timeline
BuySaleInsider track record
Carlos Costa: trading record in brief
Carlos Costa discloses dealings in Foghorn Therapeutics Inc. to SEC (Form 4). Between 16 September 2024 and 23 September 2024, the trades on record add up to 10 filings.
Sales make up the whole of the open-market record (5 sales, €530k). The rest of the record consists of 5 option exercises.
The newest entry dates from 24 September 2024: an open-market sale of €322k, in Foghorn Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Carlos Costa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,756 shares@ US$10.0444.2% of flowCommon StockSEC:0001562180-24-006927:1
- 857 shares@ US$3.720.4% of flowCommon StockSEC:0001562180-24-006927:2
- 857 shares@ US$10.171.1% of flowCommon StockSEC:0001562180-24-006927:3
- 35,756 shares@ US$3.7274.8% of flowCommon StockSEC:0001562180-24-006927:0
- 11,574 shares@ US$10.0514.4% of flowCommon StockSEC:0001562180-24-006885:1
- 11,574 shares@ US$3.7224.3% of flowCommon StockSEC:0001562180-24-006885:0
- 400 shares@ US$10.000.5% of flowCommon StockSEC:0001562180-24-006859:1
- 10,272 shares@ US$3.724.7% of flowCommon StockSEC:0001562180-24-006859:2
- 10,272 shares@ US$10.0412.8% of flowCommon StockSEC:0001562180-24-006859:3
- 400 shares@ US$3.720.8% of flowCommon StockSEC:0001562180-24-006859:0
10 of 10 declarations